Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.36 +0.14 (+1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

Cartesian Therapeutics' Return on Capital Employed [ROCE] came in at -54.91% for Q2 2026, down 32.15 percentage points from -22.75% a year earlier and down 1.36 percentage points from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025, Cartesian Therapeutics' Return on Capital Employed [ROCE] was -40.88%, down 28.23 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +70.63 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -12.65% in FY2024 (+39.02 pp), -51.67% in FY2023 (-62.22 pp), 10.55% in FY2022 (+15.63 pp) and -5.08% in FY2021 (+106.43 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q4 2023.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -1.67 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2021 (a gain of 99.16 percentage points), and the weakest in Q3 2023 (a drop of 73.97 percentage points).
  • Business Quant data shows RNAC's Return on Capital Employed [ROCE] at -53.54% (Q1 2026), -44.87% (Q4 2025) and -24.93% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Cartesian Therapeutics 216.87 Mn 216.87 Mn - -54.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54.91%
Mar 31, 2026 -53.54%
Dec 31, 2025 -44.87%
Sep 30, 2025 -24.93%
Jun 30, 2025 -22.75%
Mar 31, 2025 -12.88%
Dec 31, 2024 -10.40%
Sep 30, 2024 -14.07%
Jun 30, 2024 -15.78%
Mar 31, 2024 -29.22%
Dec 31, 2023 -62.92%
Sep 30, 2023 -56.97%
Jun 30, 2023 -39.85%
Mar 31, 2023 -10.89%
Dec 31, 2022 9.89%
Sep 30, 2022 17.00%
Jun 30, 2022 20.09%
Mar 31, 2022 11.74%
Dec 31, 2021 -5.04%
Sep 30, 2021 -21.19%
API Access

Cartesian Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEY